243 related articles for article (PubMed ID: 19136769)
41. BOB.1, CD79a and cyclin E are the most appropriate markers to discriminate classical Hodgkin's lymphoma from primary mediastinal large B-cell lymphoma.
Hoeller S; Zihler D; Zlobec I; Obermann EC; Pileri SA; Dirnhofer S; Tzankov A
Histopathology; 2010 Jan; 56(2):217-28. PubMed ID: 20102401
[TBL] [Abstract][Full Text] [Related]
42. Hodgkin's lymphoma: immunohistochemical features and its association with EBV LMP-1. Experience from a South Indian hospital.
Karnik S; Srinivasan B; Nair S
Pathology; 2003 Jun; 35(3):207-11. PubMed ID: 14506963
[TBL] [Abstract][Full Text] [Related]
43. Expression of lymphoid-associated antigens on Hodgkin's and Reed-Sternberg cells of Hodgkin's disease. An immunocytochemical study on lymph node cytospins using monoclonal antibodies.
Falini B; Stein H; Pileri S; Canino S; Farabbi R; Martelli MF; Grignani F; Fagioli M; Minelli O; Ciani C
Histopathology; 1987 Dec; 11(12):1229-42. PubMed ID: 2831131
[TBL] [Abstract][Full Text] [Related]
44. Immunohistochemical detection of CD30 remains negative in nodular lymphocyte-predominant Hodgkin's disease using enhanced antigen retrieval.
Roberts C; Jack F; Angus B; Reid A; Thompson WD
Histopathology; 2002 Feb; 40(2):166-70. PubMed ID: 11952861
[TBL] [Abstract][Full Text] [Related]
45. Follicular Hodgkin's disease.
Ashton-Key M; Thorpe PA; Allen JP; Isaacson PG
Am J Surg Pathol; 1995 Nov; 19(11):1294-9. PubMed ID: 7573692
[TBL] [Abstract][Full Text] [Related]
46. Patients suffering from both Hodgkin's disease and non-Hodgkin's lymphoma: a clinico-pathological and immuno-histochemical population-based study of 32 patients.
Amini RM; Enblad G; Sundström C; Glimelius B
Int J Cancer; 1997 May; 71(4):510-6. PubMed ID: 9178801
[TBL] [Abstract][Full Text] [Related]
47. Diagnostic accuracy of imprint cytology in the assessment of Hodgkin's disease in Japan.
Funamoto Y; Nagai M; Haba R; Ishikawa M; Kishida F; Kohno K; Matsunaga T; Kushida Y; Kobayashi S
Diagn Cytopathol; 2005 Jul; 33(1):20-5. PubMed ID: 15945083
[TBL] [Abstract][Full Text] [Related]
48. European Task Force on Lymphoma project on lymphocyte predominance Hodgkin disease: histologic and immunohistologic analysis of submitted cases reveals 2 types of Hodgkin disease with a nodular growth pattern and abundant lymphocytes.
Anagnostopoulos I; Hansmann ML; Franssila K; Harris M; Harris NL; Jaffe ES; Han J; van Krieken JM; Poppema S; Marafioti T; Franklin J; Sextro M; Diehl V; Stein H
Blood; 2000 Sep; 96(5):1889-99. PubMed ID: 10961891
[TBL] [Abstract][Full Text] [Related]
49. Cytotoxic molecule-positive classical Hodgkin's lymphoma: a clinicopathological comparison with cytotoxic molecule-positive peripheral T-cell lymphoma of not otherwise specified type.
Asano N; Kinoshita T; Tamaru J; Ohshima K; Yoshino T; Niitsu N; Tsukamoto N; Hirabayashi K; Izutsu K; Taniwaki M; Morishima Y; Nakamura S
Haematologica; 2011 Nov; 96(11):1636-43. PubMed ID: 21859738
[TBL] [Abstract][Full Text] [Related]
50. Lymphocyte-rich classical Hodgkin's lymphoma: distinctive tumor and microenvironment markers.
Nam-Cha SH; Montes-Moreno S; Salcedo MT; Sanjuan J; Garcia JF; Piris MA
Mod Pathol; 2009 Aug; 22(8):1006-15. PubMed ID: 19465900
[TBL] [Abstract][Full Text] [Related]
51. Cutaneous Hodgkin's disease: an immunohistochemical analysis.
Cerroni L; Beham-Schmid C; Kerl H
J Cutan Pathol; 1995 Jun; 22(3):229-35. PubMed ID: 7593816
[TBL] [Abstract][Full Text] [Related]
52. Prevalence and characterization of anaplastic large cell lymphoma and its association with Epstein-Barr virus in Pakistani patients.
Noorali S; Pervez S; Yaqoob N; Moatter T; Nasir MI; Haroon S; Hodges E; Smith JL
Pathol Res Pract; 2004; 200(10):669-79. PubMed ID: 15648604
[TBL] [Abstract][Full Text] [Related]
53. Composite lymphoma. A clinicopathologic analysis of nine patients with Hodgkin's disease and B-cell non-Hodgkin's lymphoma.
Gonzalez CL; Medeiros LJ; Jaffe ES
Am J Clin Pathol; 1991 Jul; 96(1):81-9. PubMed ID: 2069139
[TBL] [Abstract][Full Text] [Related]
54. Leucocyte common antigen in the differential diagnosis of Hodgkin's disease.
Strauchen JA
Hematol Oncol; 1989; 7(2):149-53. PubMed ID: 2563987
[TBL] [Abstract][Full Text] [Related]
55. Peripheral T-cell lymphoma with aberrant expression of CD30, CD15, and CD20.
Song JY; Strom T; Raffeld M; Pittaluga S; Jaffe ES
J Clin Oncol; 2011 Nov; 29(32):e789-91. PubMed ID: 21990402
[No Abstract] [Full Text] [Related]
56. CD30-positive T-cell lymphomas co-expressing CD15: an immunohistochemical analysis.
Gorczyca W; Tsang P; Liu Z; Wu CD; Dong HY; Goldstein M; Cohen P; Gangi M; Weisberger J
Int J Oncol; 2003 Feb; 22(2):319-24. PubMed ID: 12527929
[TBL] [Abstract][Full Text] [Related]
57. Coexpression of CD15 and CD20 by Reed-Sternberg cells in Hodgkin's disease.
Zukerberg LR; Collins AB; Ferry JA; Harris NL
Am J Pathol; 1991 Sep; 139(3):475-83. PubMed ID: 1716042
[TBL] [Abstract][Full Text] [Related]
58. Large B-cell lymphoma with Hodgkin's features.
García JF; Mollejo M; Fraga M; Forteza J; Muniesa JA; Pérez-Guillermo M; Pérez-Seoane C; Rivera T; Ortega P; Piris MA
Histopathology; 2005 Jul; 47(1):101-10. PubMed ID: 15982329
[TBL] [Abstract][Full Text] [Related]
59. CD20-Positive peripheral T-cell lymphoma: report of a case after nodular sclerosis Hodgkin's disease and review of the literature.
Mohrmann RL; Arber DA
Mod Pathol; 2000 Nov; 13(11):1244-52. PubMed ID: 11106083
[TBL] [Abstract][Full Text] [Related]
60. Histiocyte-rich B-cell lymphoma. A distinct clinicopathologic entity possibly related to lymphocyte predominant Hodgkin's disease, paragranuloma subtype.
Delabie J; Vandenberghe E; Kennes C; Verhoef G; Foschini MP; Stul M; Cassiman JJ; De Wolf-Peeters C
Am J Surg Pathol; 1992 Jan; 16(1):37-48. PubMed ID: 1728195
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
